Mandegary Ali, Rostami Shahrbanou, Alimoghaddam Kamran, Ghavamzadeh Ardeshir, Ghahremani Mohammad Hossein
Pharmaceutics Research Center, Department of Pharmacology and Toxicology, Faculty of Pharmacy, Kerman University of Medical Sciences, Kerman, Iran.
Asian Pac J Cancer Prev. 2011;12(5):1279-82.
Polymorphisms of glutathione S-transferase (GST) proteins are correlated with elevated risk of many cancers including hematologic malignancies. Particularly concerning acute promyelocytic leukemia (APL), the studies on association between GSTM1, GSTT1 and GSTP1 and the disease predisposition are scarce and contradictory. The aim of this study was to examine whether polymorphic variations in GST confer susceptibility to APL. GSTM1 and GSTT1 null and GSTP1 Ile105Val alleles were determined using polymerase chain reaction (PCR) and PCR-RFLP, respectively, in 114 APL patients and 99 healthy controls. Frequency of GSTT1 null and GSTM1 null genotypes were higher in APL group which it was statistically significant for GSTT1 null (p< 0.01). The GSTM1 null and GSTT1 null conferred a 1.36-fold (OR= 1.36, 95% CI = 0.79-2.33, p= 0.18) and 2.14-fold (OR= 2.14; 95% CI: 1.18-3.92, p= 0.013) increase in risk of APL, respectively, relative to the presence of the GSTM1 or GSTT1 genes. GSTP1 Ile105/Val105 and Val105/Val105 genotypes showed no increase in the risk of APL (OR= 0.94; 95% CI: 0.52-1.67 and OR= 1.12; 95% CI: 0.48-2.60, respectively). Our results suggest that GSTT1 null genotype may be associated with increased risk of APL.
谷胱甘肽S-转移酶(GST)蛋白的多态性与包括血液系统恶性肿瘤在内的多种癌症风险升高相关。特别是关于急性早幼粒细胞白血病(APL),GSTM1、GSTT1和GSTP1与该疾病易感性之间关联的研究很少且相互矛盾。本研究的目的是检查GST的多态性变异是否会使个体易患APL。分别采用聚合酶链反应(PCR)和PCR-限制性片段长度多态性(PCR-RFLP)方法,对114例APL患者和99例健康对照者检测GSTM1和GSTT1缺失以及GSTP1 Ile105Val等位基因。APL组中GSTT1缺失和GSTM1缺失基因型的频率较高,其中GSTT1缺失具有统计学意义(p<0.01)。相对于存在GSTM1或GSTT1基因,GSTM1缺失和GSTT1缺失分别使APL风险增加1.36倍(OR = 1.36,95%可信区间[CI]=0.79 - 2.33,p = 0.18)和2.14倍(OR = 2.14;95%CI:1.18 - 3.92,p = 0.013)。GSTP1 Ile105/Val105和Val105/Val105基因型未显示APL风险增加(OR分别为0.94;95%CI:0.52 - 1.67和OR = 1.12;95%CI:0.48 - 2.